505 related articles for article (PubMed ID: 27567103)
1. Research review on the pharmacological effects of astragaloside IV.
Li L; Hou X; Xu R; Liu C; Tu M
Fundam Clin Pharmacol; 2017 Feb; 31(1):17-36. PubMed ID: 27567103
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects.
Zhang J; Wu C; Gao L; Du G; Qin X
Adv Pharmacol; 2020; 87():89-112. PubMed ID: 32089240
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro.
Zhang WD; Chen H; Zhang C; Liu RH; Li HL; Chen HZ
Planta Med; 2006 Jan; 72(1):4-8. PubMed ID: 16450288
[TBL] [Abstract][Full Text] [Related]
4. The experimental study of Astragalus membranaceus on meridian tropsim: the distribution study of astragaloside IV in rat tissues.
Chang YX; Sun YG; Li J; Zhang QH; Guo XR; Zhang BL; Jin H; Gao XM
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Dec; 911():71-5. PubMed ID: 23217309
[TBL] [Abstract][Full Text] [Related]
5. [Effects of components isolated from Astragalus membranaceus Bunge on cardiac function injured by myocardial ischemia reperfusion in rats].
Zhou JY; Fan Y; Kong JL; Wu DZ; Hu ZB
Zhongguo Zhong Yao Za Zhi; 2000 May; 25(5):300-2. PubMed ID: 12512456
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV protects cardiomyocytes from anoxia/reoxygenation injury by upregulating the expression of Hes1 protein.
Huang H; Lai S; Wan Q; Qi W; Liu J
Can J Physiol Pharmacol; 2016 May; 94(5):542-53. PubMed ID: 27070866
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV protects against polymicrobial sepsis through inhibiting inflammatory response and apoptosis of lymphocytes.
Liu R; Jiang H; Tian Y; Zhao W; Wu X
J Surg Res; 2016 Jan; 200(1):315-23. PubMed ID: 26375505
[TBL] [Abstract][Full Text] [Related]
8. Effect of astragaloside IV against rat myocardial cell apoptosis induced by oxidative stress via mitochondrial ATP-sensitive potassium channels.
Guan FY; Yang SJ; Liu J; Yang SR
Mol Med Rep; 2015 Jul; 12(1):371-6. PubMed ID: 25739067
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV acts through multi-scale mechanisms to effectively reduce diabetic nephropathy.
Wang E; Wang L; Ding R; Zhai M; Ge R; Zhou P; Wang T; Fang H; Wang J; Huang J
Pharmacol Res; 2020 Jul; 157():104831. PubMed ID: 32339782
[TBL] [Abstract][Full Text] [Related]
10. Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV.
Xu Z; Zhou H; Zhang Y; Cheng Z; Wan M; Qin W; Li P; Feng J; Shao S; Xue W; Guo H; Liu B
Biomed Pharmacother; 2023 Dec; 168():115752. PubMed ID: 37875045
[TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-кB in vivo and in vitro.
Zhou X; Sun X; Gong X; Yang Y; Chen C; Shan G; Yao Q
Int Immunopharmacol; 2017 Jan; 42():18-24. PubMed ID: 27855303
[TBL] [Abstract][Full Text] [Related]
12. Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress.
Ji C; Luo Y; Zou C; Huang L; Tian R; Lu Z
BMC Pharmacol Toxicol; 2018 Sep; 19(1):53. PubMed ID: 30176914
[TBL] [Abstract][Full Text] [Related]
13. [Research advances on astragaloside-IV in treatment of diabetes mellitus and its complications pharmacological effects].
You LZ; Lin YX; Fang ZH; Shen GM; Zhao JD; Wang TT
Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(24):4700-4706. PubMed ID: 29493134
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV ameliorates early diabetic nephropathy by inhibition of MEK1/2-ERK1/2-RSK2 signaling in streptozotocin-induced diabetic mice.
Song G; Han P; Sun H; Shao M; Yu X; Wang W; Wang D; Yi W; Ge N; Li S; Yi T
J Int Med Res; 2018 Jul; 46(7):2883-2897. PubMed ID: 29896981
[TBL] [Abstract][Full Text] [Related]
15. Effects of cycloartane saponins from hairy roots of Astragalus membranaceus Bge., on human tumor cell targets.
Ionkova I; Momekov G; Proksch P
Fitoterapia; 2010 Jul; 81(5):447-51. PubMed ID: 20060881
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells.
Liu H; Wei W; Sun WY; Li X
J Ethnopharmacol; 2009 Apr; 122(3):502-8. PubMed ID: 19429320
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia.
Luo Y; Qin Z; Hong Z; Zhang X; Ding D; Fu JH; Zhang WD; Chen J
Neurosci Lett; 2004 Jun; 363(3):218-23. PubMed ID: 15182947
[TBL] [Abstract][Full Text] [Related]
18. [Inhibiting effects of three components of Astragalus membranaceus on oxidative stress in Chang Liver cells].
Li J; Han L; Ma YF; Huang YF
Zhongguo Zhong Yao Za Zhi; 2015 Jan; 40(2):318-23. PubMed ID: 26080566
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV inhibits adenovirus replication and apoptosis in A549 cells in vitro.
Shang L; Qu Z; Sun L; Wang Y; Liu F; Wang S; Gao H; Jiang F
J Pharm Pharmacol; 2011 May; 63(5):688-94. PubMed ID: 21492171
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV attenuates complement membranous attack complex induced podocyte injury through the MAPK pathway.
Zheng R; Deng Y; Chen Y; Fan J; Zhang M; Zhong Y; Zhu R; Wang L
Phytother Res; 2012 Jun; 26(6):892-8. PubMed ID: 22086717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]